Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study explores the potential benefits of a sugar water solution for decreasing pain in infants during routine immunizations.
| Condition | Intervention |
|---|---|
|
Pain Procedural Pain |
Behavioral: Sucrose |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Efficacy of Oral Sucrose Analgesia During Routine Immunizations at 6 Weeks and 4 Months of Age |
- The University of Wisconsin Children’s Hospital Pain Scale will measure the primary outcome acute behavioral pain response. Measure will be recorded at baseline, immediately after immunizations and 3 minutes following immunizations
- Duration of analgesia during immunizations
- Age related changes in behavioral pain response during immunizations
| Estimated Enrollment: | 140 |
| Study Start Date: | November 2003 |
Acute pain during early life may alter infant pain responses, cognitive development, and behavioral outcomes. Immunization injections represent a relatively brief exposure to acute pain, yet assessment studies demonstrate that infants respond with significant distress during the injections. This study will examine the analgesic potential of oral sucrose in diminishing the pain associated with immunization injections in 6 week to 4-month-old infants. The proposed mechanism of action is via the activation of endogenous opioids that attenuate nociceptive information at the level of the dorsal horn.
Comparison: Administration of oral sucrose 2 minutes prior to immunizations compared to administration of sterile water 2 minutes prior to immunizations
Eligibility| Ages Eligible for Study: | 6 Weeks to 4 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Currently between 2 and 4 months of age
- Birth between 37 and 42 weeks’ completed gestation;
- Birth weight greater than 2.5 kg
- No evidence of acute or chronic disease processes.
Exclusion Criteria:
- They are experiencing concurrent illness
- They received an analgesic/sedative 6 hours prior to the office visit
- The infant has breast fed 30 minutes prior to the visit or wishes to breast feed during or immediately after the immunization
- The infant has been introduced to solid food
- The infant may not receive a pacifier
- The infant is diagnosed with a major congenital disorder where the behavioral responses to painful stimuli may be altered
- Language barriers preclude the process of obtaining parental consent.
Contacts and Locations| United States, Pennsylvania | |
| General Ambulatory Pediatric Clinic, Penn State Children's Hospital | |
| Hershey, Pennsylvania, United States, 17033 | |
| Principal Investigator: | Linda A Hatfield, PhD(c) CNNP | Penn State College of Medicine, Penn State Milton S. Hershey Medical Center’ |
More Information
No publications provided by Penn State University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00150189 History of Changes |
| Other Study ID Numbers: | IRB NO. 2003-315 |
| Study First Received: | September 6, 2005 |
| Last Updated: | December 22, 2006 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Penn State University:
|
Pain Procedural Pain Sucrose Infant Newborn |
ClinicalTrials.gov processed this record on May 19, 2013